-
MilliporeSigma and Baylor Enter COVID-19 Vax Pact
contractpharma
June 03, 2020
Will focus on process development and improvements for manufacturing Baylor's Covid-19 vaccine candidates.
-
MilliporeSigma, Baylor College of Medicine to Advance COVID-19 Vaccine Manufacturing Platform
americanpharmaceuticalreview
May 29, 2020
MilliporeSigma and Baylor College of Medicine have announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, accelerating the transition to Phase 1 clinical trials.
-
MilliporeSigma Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing
americanpharmaceuticalreview
April 17, 2020
MilliporeSigma and The Jenner Institute announced The Jenner Institute has laid the foundation for large-scale production of its Covid-19 vaccine candidate, ChAdOx1 nCoV-19.
-
Jenner Institute, MilliporeSigma to Scale Up Covid-19 Vax Production
contractpharma
April 15, 2020
Develops a rapid, scalable platform following good manufacturing practices and using disposable technologies.
-
MilliporeSigma Launches LANEXO
contractpharma
March 05, 2020
Digital laboratory informatics solution aims to reduce time in labs and improve data quality and traceability.
-
MilliporeSigma Granted 20 CRISPR Patents Total Worldwide
americanpharmaceuticalreview
August 21, 2019
MilliporeSigma, a leader in genome editing, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing MilliporeSigma's patent application claims covering CRISPR gene-editing technol
-
MilliporeSigma Acquires BSSN Software
contractpharma
August 07, 2019
Aims to accelerate digital transformation in the lab.
-
MilliporeSigma Launches Plug & Play Upstream Development Service
contractpharma
August 02, 2019
Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-ups.
-
MilliporeSigma, Broad Institute Announce CRISPR License Framework
contractpharma
July 19, 2019
New framework aims to simplify and accelerate access to CRISPR IP for research.
-
MilliporeSigma awards grants to Biotech companies
biospectrumasia
June 03, 2019
Three U.S. companies awarded MilliporeSigma’s Advance Biotech Grant to advance molecule-to-market efforts